Nucleus RadioPharma - Crunchbase Company Profile & Funding

Q: Who invested in Nucleus RadioPharma?

Nucleus RadioPharma has 10 investors including OrbiMed And AstraZeneca.

Q: How much funding has Nucleus RadioPharma raised to date?

Nucleus RadioPharma has raised obfuscated.

Overview

Nucleus RadioPharma

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Nucleus RadioPharma

CB Rank

13952

Nucleus RadioPharma is a new company built to ensure cancer patients can access potentially life-saving radiopharmaceuticals.

Founded

obfuscation

Private

Private Equity

Rochester, Minnesota, United States

51-100

www.nucleusrad.com

Health Care

Funding Rounds

Private Equity

OBF

obfuscation

Series A

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Stephen Hahn: Chief Executive Officer
Past Role: Harbinger Health, CEO at Harbinger Health, CEO-Partner at Flagship Pioneering
Kimberly Blackwell: Chief Development Officer
Past Role: Zentalis Pharmaceuticals, Chief Executive Officer

Details

Legal Name

Nucleus RadioPharma Inc.

Operating Status

Active

Company Type

For Profit

Founders

Charles Conroy

About the Company

Nucleus RadioPharma is a new company that was founded to ensure that cancer patients have access to potentially life-saving radiopharmaceuticals by developing technologies to modernise the clinical development, manufacturing, and supply chain of these promising new therapies.

Contact Email

info@nucleusrad.com

Predictions & Insights

Growth Insight

See this Growth Insight

Nucleus RadioPharma is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

Contract Development and Manufacturing Organization (CDMO) Services for Targeted Radiotherapies

End-to-end CDMO services supporting radiopharmaceutical development from early research through commercial manufacturing and supply chain management.

Research and Development (R&D) Services for Radiopharmaceuticals

Dedicated R&D space and expertise to support preclinical research and formulation development of radiopharmaceutical therapies.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Private Equity Round - Nucleus RadioPharma	1	obfuscated obfuscation	OrbiMed	Private Equity
obfuscated obfuscation	Private Equity Round - Nucleus RadioPharma	1	obfuscated obfuscation	OrbiMed	Private Equity
obfuscated obfuscation	Private Equity Round - Nucleus RadioPharma	1	obfuscated obfuscation	OrbiMed	Private Equity
obfuscated obfuscation	Private Equity Round - Nucleus RadioPharma	1	obfuscated obfuscation	OrbiMed	Private Equity
obfuscated obfuscation	Private Equity Round - Nucleus RadioPharma	1	obfuscated obfuscation	OrbiMed	Private Equity

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Private Equity Round - Nucleus RadioPharma	1	obfuscated obfuscation	OrbiMed	Private Equity
obfuscated obfuscation	Private Equity Round - Nucleus RadioPharma	1	obfuscated obfuscation	OrbiMed	Private Equity
obfuscated obfuscation	Private Equity Round - Nucleus RadioPharma	1	obfuscated obfuscation	OrbiMed	Private Equity
obfuscated obfuscation	Private Equity Round - Nucleus RadioPharma	1	obfuscated obfuscation	OrbiMed	Private Equity
obfuscated obfuscation	Private Equity Round - Nucleus RadioPharma	1	obfuscated obfuscation	OrbiMed	Private Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
OrbiMed	Yes	Private Equity Round - Nucleus RadioPharma	Matthew S. Rizzo
OrbiMed	Yes	Private Equity Round - Nucleus RadioPharma	Matthew S. Rizzo
OrbiMed	Yes	Private Equity Round - Nucleus RadioPharma	Matthew S. Rizzo
OrbiMed	Yes	Private Equity Round - Nucleus RadioPharma	Matthew S. Rizzo
OrbiMed	Yes	Private Equity Round - Nucleus RadioPharma	Matthew S. Rizzo